Nifedipine Tablet, Extended Release
Product Images NDC 68788-8164

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Nifedipine (NDC 68788-8164). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Nifedipine Extended-release Tab Usp 60mg (Cda16a27 F029 40a6 A0e8 2bed0de71169 00)

This is a description of a medication called Nifedipine Extended-Release Tab used to treat hypertension and angina. However, it contains a warning that the federal law forbids the transfer of the drug to anyone except the patient it was prescribed for. It is a generic version of Procardia XL with each tablet containing 60mg of Nifedipine USP. The manufacturer of this drug is Ingenus Pharmaceuticals, LLC. The text also includes information on the package size, lot and batch numbers, expiration date and the corresponding product and insurance NDC numbers. The last section seems to be a billing chart log related to the medication's sales.*

FDA Label Image

01 (Image 01)

FDA Label Image

02 (Image 02)

This is a table showing the percentages of adverse effects experienced by patients taking Nifedipine extended-release tablets and placebo. The adverse effects listed include headache, fatigue, dizziness, constipation, and nausea. The numbers in the table represent the percentage of patients who experienced the specific adverse effect.*

FDA Label Image

03 (Image 03)

This is a table comparing the percentage of adverse effects in patients taking nifedipine capsules versus those taking a placebo. The adverse effects listed include dizziness, lightheadedness, giddiness, flushing, heat sensation, headache, weakness, nausea, heartburn, muscle cramps, tremor, peripheral edema, nervousness, mood changes, palpitations, dyspnea, cough, wheezing, nasal congestion, and sore throat.*

FDA Label Image

04 (Image 04)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.